Title: LEGISLATIVE BILL 697
Official Title: LEGISLATIVE BILL 697
Number of Sections: 2
Source: versions - Introduced
Media Type: application/pdf
Strikethrough Detection: 5 sections found

================================================================================

Section 1:
LB697 LB697
2025 2025
LEGISLATURE OF NEBRASKA
ONE HUNDRED NINTH LEGISLATURE
FIRST SESSION
Introduced by Strommen, 47; Bosn, 25; DeBoer, 10; DeKay, 40; Dover, 19;
Dungan, 26; Fredrickson, 20; Guereca, 7; Hallstrom, 1;
Holdcroft, 36; Hunt, 8; Ibach, 44; Kauth, 31; Lonowski, 33;
Quick, 35; Rountree, 3; Sorrentino, 39; Spivey, 13; Storer,

Section 2:
43.
Read first time January 22, 2025
Committee: Health and Human Services
1 A BILL FOR AN ACT relating to the Pharmacy Practice Act; to amend
2 sections 38-2849 and 38-2884, Reissue Revised Statutes of Nebraska,
3 and section 38-2867.01, Revised Statutes Cumulative Supplement,
4 2024; to change requirements for the Board of Pharmacy; to change
5 requirements relating to compounding and delegated dispensing
6 permits; and to repeal the original sections.
7 Be it enacted by the people of the State of Nebraska,
-1-
LB697 LB697
2025 2025
1 Section 1. Section 38-2849, Reissue Revised Statutes of Nebraska, is
2 amended to read:
3 38-2849 The board shall be composed of eight five members, including
4 five four actively practicing pharmacists, at least one of whom practices
5 within the confines of a hospital, one pharmacy technician, and two one
6 public members member who are is interested in the health of the people
7 of Nebraska.
8 Sec. 2. Section 38-2867.01, Revised Statutes Cumulative Supplement,
9 2024, is amended to read:
10 38-2867.01 (1) Any person authorized to compound shall compound in
11 compliance with the standards of chapters 795 and 797 of The United
12 States Pharmacopeia and The National Formulary, as such chapters existed
13 on January 1, 2023, and shall compound (a) as the result of a
14 practitioner's medical order or initiative occurring in the course of
15 practice based upon the relationship between the practitioner, patient,
16 and pharmacist, (b) for the purpose of, or as an incident to, research,
17 teaching, or chemical analysis and not for sale or dispensing, or (c) for
18 office use only and not for resale by an outsourcing facility operating
19 pursuant to 21 U.S.C. 353b or section 71-470.
20 (2) Compounding in a hospital pharmacy may occur for any hospital
21 which is part of the same health care system under common ownership or
22 which is a member of or an affiliated member of a formal network or
23 partnership agreement.
24 (3)(a) Any authorized person may reconstitute a commercially
25 available drug product in accordance with directions contained in
26 approved labeling provided by the product's manufacturer and other
27 manufacturer directions consistent with labeling.
28 (b) Any authorized person using beyond-use dating must follow the
29 approved product manufacturer's labeling or the standards of The United
30 States Pharmacopeia and The National Formulary if the product
31 manufacturer's labeling does not specify beyond-use dating.
-2-
LB697 LB697
2025 2025
1 (c) Any authorized person engaged in activities listed in this
2 subsection is not engaged in compounding, except that any variance from
3 the approved product manufacturer's labeling will result in the person
4 being engaged in compounding.
5 (4) Any authorized person splitting a scored tablet along scored
6 lines or adding flavoring to a commercially available drug product is not
7 engaged in compounding.
8 (5) No person shall compound:
9 (a) A drug that has been identified by the federal Food and Drug
10 Administration as withdrawn or removed from the market because the drug
11 was found to be unsafe or ineffective;
12 (b) A drug that is essentially a copy of an approved drug unless
13 there is a drug shortage as determined by the board or unless a patient
14 has an allergic reaction to the approved drug; or
15 (c) A drug that has been identified by the federal Food and Drug
16 Administration or the board as a product which may not be compounded.
17 Sec. 3. Section 38-2884, Reissue Revised Statutes of Nebraska, is
18 amended to read:
19 38-2884 Under a delegated dispensing permit for a public health
20 clinic, approved formulary drugs and devices may be dispensed by a public
21 health clinic worker or a health care professional licensed in Nebraska
22 to practice medicine and surgery or licensed in Nebraska as a registered
23 nurse, licensed practical nurse, or physician assistant without the
24 onsite services of a pharmacist if:
25 (1) The initial dispensing of all prescriptions for approved
26 formulary drugs and devices is conducted by a health care professional
27 licensed in Nebraska to practice medicine and surgery or pharmacy or
28 licensed in Nebraska as a registered nurse, licensed practical nurse, or
29 physician assistant;
30 (2) The drug or device is dispensed pursuant to a prescription
31 written onsite by a practitioner or by a practitioner licensed in
-3-
LB697 LB697
2025 2025
1 Nebraska working in affiliation with a public health clinic pursuant to a
2 delegated dispensing permit;
3 (3) The only prescriptions to be refilled under the delegated
4 dispensing permit are prescriptions for contraceptives;
5 (4) Prescriptions are accompanied by patient instructions and
6 written information approved by the director;
7 (5) The dispensing of authorized refills of contraceptives is done
8 by a licensed health care professional listed in subdivision (1) of this
9 section or by a public health clinic worker;
10 (6) All drugs or devices are prepackaged by the manufacturer or at a
11 public health clinic by a pharmacist into the quantity to be prescribed
12 and dispensed at the public health clinic;
13 (7) All drugs and devices stored, received, or dispensed under the
14 authority of public health clinics are properly labeled at all times. For
15 purposes of this subdivision, properly labeled means that the label
16 affixed to the container prior to dispensing contains the following
17 information:
18 (a) The name of the manufacturer;
19 (b) The lot number and expiration date from the manufacturer or, if
20 repackaged by a pharmacist, the lot number and calculated expiration
21 date;
22 (c) Directions for patient use;
23 (d) The quantity of drug in the container;
24 (e) The name, strength, and dosage form of the drug; and
25 (f) Auxiliary labels as needed for proper adherence to any
26 prescription;
27 (8) The following additional information is added to the label of
28 each container when the drug or device is dispensed:
29 (a) The patient's name;
30 (b) The name of the prescribing health care professional;
31 (c) The prescription number;
-4-
LB697 LB697
2025 2025
1 (d) The date dispensed; and
2 (e) The name and address of the public health clinic;
3 (9) The only drugs and devices allowed to be dispensed or stored by
4 public health clinics appear on the formulary approved pursuant to
5 section 38-2881; and
6 (10) At any time that dispensing is occurring from a public health
7 clinic, the delegating pharmacist for the public health clinic or on-call
8 pharmacist in Nebraska is available, either in person or by telephone, to
9 answer questions from clients, staff, public health clinic workers, or
10 volunteers. This availability shall be confirmed and documented at the
11 beginning of each day that dispensing will occur. The delegating
12 pharmacist or on-call pharmacist shall inform the public health clinic if
13 he or she will not be available during the time that his or her
14 availability is required. If a pharmacist is unavailable, no dispensing
15 shall occur.
16 Sec. 4. Original sections 38-2849 and 38-2884, Reissue Revised
17 Statutes of Nebraska, and section 38-2867.01, Revised Statutes Cumulative
18 Supplement, 2024, are repealed.
-5-
[DELETED: ySA B F A A r t t P P A t asa s 3 R S C S2 t c r f t B o P t cr r t c a d dpB7L52]
[DELETED: Sa3fwpoS2031c w t s o c 7 a 7 o T U2S3o J 1 2 a s c ( a t r o 4p m o o i o i t c o5p6a7t8o9p0( C i a h p m o f a h1w2w i a m o o a a m o a f n o3p4( A a p m r a c5a d p i a w d c i6a l p b t p m a o7m8( A a p u b d m f t9a0S P a T N F i t p1m7L52]
[DELETED: ( A a p e i a l i tst a p m l w r i t pb( A a p s a s t a sle(( A d t h b i b t f F a D0A1w2( A d t i e a c o a a d u3t4h5( A d t h b i b t f F a D6A7S 3 S 3 R R S o N i8a93 U a d d p f a p h0c1h2t3n l p n o p a w t4o5( T i d o a p f a6f7l i N t p m a s o p o8l9p0( T d o d i d p t a p1w o b a p o b a p l i7L52]
[DELETED: Nd( T o p t b r u t dd( P a a b p i aw(bs0(1p2a3(4a5p o t s p l m t t l6a t t c p t d c t f7i8(9(0r b a p t l n a c e1d2(3(4(5( A l a n f p a t a6p7( T f a i i a t t l o8e9(0(1(7L52]
[DELETED: (((p h c a o t f a p ts(cpa q f c s p h c w o0v T a s b c a d a t1b o e d t d w o T d2p3h o s w n b a d t t t h o h4a5s6S 4  O s 3 a 3 R R7S8S7L52]


================================================================================

Raw Text:
LB697 LB697
2025 2025
LEGISLATURE OF NEBRASKA
ONE HUNDRED NINTH LEGISLATURE
FIRST SESSION
LEGISLATIVE BILL 697
Introduced by Strommen, 47; Bosn, 25; DeBoer, 10; DeKay, 40; Dover, 19;
Dungan, 26; Fredrickson, 20; Guereca, 7; Hallstrom, 1;
Holdcroft, 36; Hunt, 8; Ibach, 44; Kauth, 31; Lonowski, 33;
Quick, 35; Rountree, 3; Sorrentino, 39; Spivey, 13; Storer,
43.
Read first time January 22, 2025
Committee: Health and Human Services
1 A BILL FOR AN ACT relating to the Pharmacy Practice Act; to amend
2 sections 38-2849 and 38-2884, Reissue Revised Statutes of Nebraska,
3 and section 38-2867.01, Revised Statutes Cumulative Supplement,
4 2024; to change requirements for the Board of Pharmacy; to change
5 requirements relating to compounding and delegated dispensing
6 permits; and to repeal the original sections.
7 Be it enacted by the people of the State of Nebraska,
-1-

LB697 LB697
2025 2025
1 Section 1. Section 38-2849, Reissue Revised Statutes of Nebraska, is
2 amended to read:
3 38-2849 The board shall be composed of eight five members, including
4 five four actively practicing pharmacists, at least one of whom practices
5 within the confines of a hospital, one pharmacy technician, and two one
6 public members member who are is interested in the health of the people
7 of Nebraska.
8 Sec. 2. Section 38-2867.01, Revised Statutes Cumulative Supplement,
9 2024, is amended to read:
10 38-2867.01 (1) Any person authorized to compound shall compound in
11 compliance with the standards of chapters 795 and 797 of The United
12 States Pharmacopeia and The National Formulary, as such chapters existed
13 on January 1, 2023, and shall compound (a) as the result of a
14 practitioner's medical order or initiative occurring in the course of
15 practice based upon the relationship between the practitioner, patient,
16 and pharmacist, (b) for the purpose of, or as an incident to, research,
17 teaching, or chemical analysis and not for sale or dispensing, or (c) for
18 office use only and not for resale by an outsourcing facility operating
19 pursuant to 21 U.S.C. 353b or section 71-470.
20 (2) Compounding in a hospital pharmacy may occur for any hospital
21 which is part of the same health care system under common ownership or
22 which is a member of or an affiliated member of a formal network or
23 partnership agreement.
24 (3)(a) Any authorized person may reconstitute a commercially
25 available drug product in accordance with directions contained in
26 approved labeling provided by the product's manufacturer and other
27 manufacturer directions consistent with labeling.
28 (b) Any authorized person using beyond-use dating must follow the
29 approved product manufacturer's labeling or the standards of The United
30 States Pharmacopeia and The National Formulary if the product
31 manufacturer's labeling does not specify beyond-use dating.
-2-

LB697 LB697
2025 2025
1 (c) Any authorized person engaged in activities listed in this
2 subsection is not engaged in compounding, except that any variance from
3 the approved product manufacturer's labeling will result in the person
4 being engaged in compounding.
5 (4) Any authorized person splitting a scored tablet along scored
6 lines or adding flavoring to a commercially available drug product is not
7 engaged in compounding.
8 (5) No person shall compound:
9 (a) A drug that has been identified by the federal Food and Drug
10 Administration as withdrawn or removed from the market because the drug
11 was found to be unsafe or ineffective;
12 (b) A drug that is essentially a copy of an approved drug unless
13 there is a drug shortage as determined by the board or unless a patient
14 has an allergic reaction to the approved drug; or
15 (c) A drug that has been identified by the federal Food and Drug
16 Administration or the board as a product which may not be compounded.
17 Sec. 3. Section 38-2884, Reissue Revised Statutes of Nebraska, is
18 amended to read:
19 38-2884 Under a delegated dispensing permit for a public health
20 clinic, approved formulary drugs and devices may be dispensed by a public
21 health clinic worker or a health care professional licensed in Nebraska
22 to practice medicine and surgery or licensed in Nebraska as a registered
23 nurse, licensed practical nurse, or physician assistant without the
24 onsite services of a pharmacist if:
25 (1) The initial dispensing of all prescriptions for approved
26 formulary drugs and devices is conducted by a health care professional
27 licensed in Nebraska to practice medicine and surgery or pharmacy or
28 licensed in Nebraska as a registered nurse, licensed practical nurse, or
29 physician assistant;
30 (2) The drug or device is dispensed pursuant to a prescription
31 written onsite by a practitioner or by a practitioner licensed in
-3-

LB697 LB697
2025 2025
1 Nebraska working in affiliation with a public health clinic pursuant to a
2 delegated dispensing permit;
3 (3) The only prescriptions to be refilled under the delegated
4 dispensing permit are prescriptions for contraceptives;
5 (4) Prescriptions are accompanied by patient instructions and
6 written information approved by the director;
7 (5) The dispensing of authorized refills of contraceptives is done
8 by a licensed health care professional listed in subdivision (1) of this
9 section or by a public health clinic worker;
10 (6) All drugs or devices are prepackaged by the manufacturer or at a
11 public health clinic by a pharmacist into the quantity to be prescribed
12 and dispensed at the public health clinic;
13 (7) All drugs and devices stored, received, or dispensed under the
14 authority of public health clinics are properly labeled at all times. For
15 purposes of this subdivision, properly labeled means that the label
16 affixed to the container prior to dispensing contains the following
17 information:
18 (a) The name of the manufacturer;
19 (b) The lot number and expiration date from the manufacturer or, if
20 repackaged by a pharmacist, the lot number and calculated expiration
21 date;
22 (c) Directions for patient use;
23 (d) The quantity of drug in the container;
24 (e) The name, strength, and dosage form of the drug; and
25 (f) Auxiliary labels as needed for proper adherence to any
26 prescription;
27 (8) The following additional information is added to the label of
28 each container when the drug or device is dispensed:
29 (a) The patient's name;
30 (b) The name of the prescribing health care professional;
31 (c) The prescription number;
-4-

LB697 LB697
2025 2025
1 (d) The date dispensed; and
2 (e) The name and address of the public health clinic;
3 (9) The only drugs and devices allowed to be dispensed or stored by
4 public health clinics appear on the formulary approved pursuant to
5 section 38-2881; and
6 (10) At any time that dispensing is occurring from a public health
7 clinic, the delegating pharmacist for the public health clinic or on-call
8 pharmacist in Nebraska is available, either in person or by telephone, to
9 answer questions from clients, staff, public health clinic workers, or
10 volunteers. This availability shall be confirmed and documented at the
11 beginning of each day that dispensing will occur. The delegating
12 pharmacist or on-call pharmacist shall inform the public health clinic if
13 he or she will not be available during the time that his or her
14 availability is required. If a pharmacist is unavailable, no dispensing
15 shall occur.
16 Sec. 4. Original sections 38-2849 and 38-2884, Reissue Revised
17 Statutes of Nebraska, and section 38-2867.01, Revised Statutes Cumulative
18 Supplement, 2024, are repealed.
-5-

[DELETED: ySA B F A A r t t P P A t asa s 3 R S C S2 t c r f t B o P t cr r t c a d dpB7L52]
[DELETED: Sa3fwpoS2031c w t s o c 7 a 7 o T U2S3o J 1 2 a s c ( a t r o 4p m o o i o i t c o5p6a7t8o9p0( C i a h p m o f a h1w2w i a m o o a a m o a f n o3p4( A a p m r a c5a d p i a w d c i6a l p b t p m a o7m8( A a p u b d m f t9a0S P a T N F i t p1m7L52]
[DELETED: ( A a p e i a l i tst a p m l w r i t pb( A a p s a s t a sle(( A d t h b i b t f F a D0A1w2( A d t i e a c o a a d u3t4h5( A d t h b i b t f F a D6A7S 3 S 3 R R S o N i8a93 U a d d p f a p h0c1h2t3n l p n o p a w t4o5( T i d o a p f a6f7l i N t p m a s o p o8l9p0( T d o d i d p t a p1w o b a p o b a p l i7L52]
[DELETED: Nd( T o p t b r u t dd( P a a b p i aw(bs0(1p2a3(4a5p o t s p l m t t l6a t t c p t d c t f7i8(9(0r b a p t l n a c e1d2(3(4(5( A l a n f p a t a6p7( T f a i i a t t l o8e9(0(1(7L52]
[DELETED: (((p h c a o t f a p ts(cpa q f c s p h c w o0v T a s b c a d a t1b o e d t d w o T d2p3h o s w n b a d t t t h o h4a5s6S 4  O s 3 a 3 R R7S8S7L52]